
OlarteMoure is sought after by high-profile international life sciences clients, including Pfizer, GSK, and Johnson & Johnson, to manage the full lifecycle of pharmaceutical and biotechnology operations and commercialisation. Collaborating closely with the firm’s broader competition, compliance, and IP enforcement teams, the group is well-equipped to address patent drafting and filing, regulatory market access, pricing strategies, and antitrust-sensitive commercialisation structures, along with extensive experience in high-stakes patent prosecution and litigation. Key figures in the practice include founding partner Carlos Olarte, a qualified biomedical and mechanical engineer, who brings substantial experience in representing pharmaceutical companies in patent drafting, dispute resolution and portfolio management. Patent director Mónica Guevara leverages her pharmaceutical chemistry background to assist clients with patentability assessments, application drafting, and prosecution. Compliance Director Catalina Jiménez Abadía oversees corporate issues related to pharmaceutical transactions. Recently, the team welcomed IP and public health specialist of counsel Liliana Ariza in October 2025. However, the group has also experienced some departures, with Patent Litigation Director Liliana Galindo leaving in March 2025, followed by former Regulatory Affairs Director Alexander Agudelo in July 2025. His replacement, Mauricio Ávila, subsequently departed the firm in September 2025.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- They are excellent at their job, close to the business and with practical concepts.
- Their experience and personal touch. Flexible pricing.
- OLARTEMOURE is highly experienced in providing compliance consulting services for the life sciences sector. They possess extensive experience and knowledge in specific areas related to the regular operations of public institutions in Colombia. Furthermore, they have a strong understanding of administrative procedures, policies, codes of ethics, and core corporate compliance concepts. They also offer prompt, reliable, and effective client service.
- OLARTEMOURE is highly experienced in providing compliance consulting services for the life sciences sector. They possess extensive experience and knowledge in specific areas related to the regular operations of public institutions in Colombia. Furthermore, they have a strong understanding of administrative procedures, policies, codes of ethics, and core corporate compliance concepts. They also offer prompt, reliable, and effective client service.
Key clients
- Merck & Co.
- Bristol Myers Squibb
- Eli Lilly and Company
- Pfizer
- Chiesi
- Panacea-Velvack
- Bayer Intellectual Property
- Heidelberg Pharma Research
- Vertex Pharmaceuticals Incorporated
- Johnson & Johnson
- Novartis AG
- Sarepta
- Amgen
- N.V. Organon
- GlaxoSmithKline
- Daichii Sankyo
- PTC Therapeutics
- ASTELLAS PHARMA COLOMBIA
Work highlights
Advised Eli Lilly & Company on reconsideration actions against INVIMAs denial of data exclusivity based on alleged molecular similarity for two of Lilly's humanised monoclonal antibody products.
Assisting Bristol Myers Squibb with prosecuting its patent portfolio in Latin America.
Assisted Panacea with patent drafting, patent prosecution and IP strategy.
Lawyers
Hall of Fame
The lawyers at the very top of the profession, widely known and respected by peers and clients for their longstanding involvement in market-leading work.

Practice head
Carlos R. Olarte; Mónica Guevara; Catalina Jiménez Abadía; Liliana Ariza
